Table 2.
Genotype | IP, µg/mg AIR | Relative abundance of IP peak, % |
Col-0 | 8.23 ± 1.33 | 100 |
xxt1 xxt2 | n.d. | n.d. |
clsc456812 | n.d. | n.d. |
cslc45612 | 1.00 ± 0.61* | 12.2 |
cslc4568 | 1.02 ± 0.53* | 12.4 |
cslc456-2 | 1.87 ± 0.55* | 22.7 |
cslc456-1 | 3.40 ± 0.96* | 41.3 |
clsc12-2 | 9.60 ± 2.38 | 116.6 |
cslc8-1 | 10.11 ± 2.11 | 122.8 |
cslc6-1 | 8.18 ± 0.87 | 99.4 |
clsc5-1 | 7.54 ± 1.25 | 91.5 |
cslc4-3 | 8.09 ± 2.47 | 98.3 |
The IP content was determined using HPAEC (Fig. 4). IP quantification (µg/mg AIR) was determined using maltose as an internal standard. The IP values were obtained from three biological replicates (n = 3, ±SD). Asterisks indicate statistically significant differences from Col-0, (Student’s t test, P < 0.05). The relative abundance of the IP peak in the samples was calculated with respect to Col-0. n.d., not detected.